No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Microbix Q4 Net Income Drops, but Revenue Jumps 48%
Microbix Biosystems Inc: MDA EN
Microbix Biosystems Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
Microbix Schedules Release of Results for Q4 Fiscal 2024
Microbix Launches Genetic-Test Program to Find Patients Susceptible to Hearing Loss After Use of Antibiotics
Microbix Assisting EMQN With Novel Genetic-Test EQA Program